These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7022966)

  • 41. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B-cell alloantibodies and clinical kidney transplantation.
    Myburgh JA; Smit JA; Maier G; Meyers AM
    S Afr J Surg; 1978 Mar; 16(1):5-10. PubMed ID: 362561
    [No Abstract]   [Full Text] [Related]  

  • 43. HLA class II DP epitopes.
    Deng CT; Cai J; Ozawa M; El-Awar N
    Clin Transpl; 2007; ():195-202. PubMed ID: 18637470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful transplantation across positive crossmatches: a result of detailed pretransplant antibody analysis.
    Wetzsteon PJ; Head MA; Fletcher LA; Barry JM; Norman DJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):714-5. PubMed ID: 2650237
    [No Abstract]   [Full Text] [Related]  

  • 46. Significant factors influencing kidney graft survival.
    van Rood JJ; Persijn GG; Paul LC; Cohen B; Lansbergen Q; Goulmy E; Claas FH; Baldwin W; van Es LA
    Transplant Proc; 1981 Mar; 13(1 Pt 2):909-12. PubMed ID: 7022960
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
    Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
    Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoantibodies in patients on dialysis awaiting renal transplantation.
    Ettenger RB; Robinson B; Louie J; Malekzadeh MH; Pennisi AJ; Jordan SC; Uittenbogaart CH; Fine RN
    Proc Clin Dial Transplant Forum; 1979; 9():205-8. PubMed ID: 399508
    [No Abstract]   [Full Text] [Related]  

  • 49. HLA-DR3 associated with improved kidney transplant survival.
    Cicciarelli JC; Perdue S; Terasaki PI
    Transplant Proc; 1982 Jun; 14(2):308-10. PubMed ID: 7051472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sucessful renal allograft in the presence of York (Yka) and autologous B-cell antibodies.
    Connors SM; Myrberg SJ; Dodds K; Carpenter CB; Garovoy MR
    Transplant Proc; 1979 Dec; 11(4):1944-6. PubMed ID: 394438
    [No Abstract]   [Full Text] [Related]  

  • 52. [Renal transplantation in recipients with positive cross-reaction against B lymphocytes].
    de Paula FJ; de Oliveira MA; Ianhez LE; Chocair PR; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(2):72-5. PubMed ID: 3912937
    [No Abstract]   [Full Text] [Related]  

  • 53. B-cell alloantigen matching by the lymphocyte insulin receptor assay.
    Helderman JH; Garovoy MR; Strom TB
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1042-3. PubMed ID: 6455812
    [No Abstract]   [Full Text] [Related]  

  • 54. Pronase improves detection of HLA antibodies in flow crossmatches.
    Vaidya S; Cooper TY; Stewart D; Gugliuzza K; Daller J; Bray RA
    Transplant Proc; 2001; 33(1-2):473-4. PubMed ID: 11266914
    [No Abstract]   [Full Text] [Related]  

  • 55. Noncytotoxic antibodies and renal transplant outcome. A prospective study.
    MacLeod AM; Stewart KN; Mather A; Engeset J; Edward N; Catto GR
    Transplantation; 1987 Dec; 44(6):840-2. PubMed ID: 3321594
    [No Abstract]   [Full Text] [Related]  

  • 56. Most positive B cell crossmatches are not caused by anti-HLA-DR antibodies.
    d'Apice AJ; Tait BD
    Transplantation; 1980 Nov; 30(5):382-3. PubMed ID: 7006169
    [No Abstract]   [Full Text] [Related]  

  • 57. Chimpanzee antibodies to purified human Ia-like B cell antigens.
    Ward FE; Johnson AH; Metzgar RS; Strong DM; Cresswell P
    Transplantation; 1981 Jul; 32(1):45-7. PubMed ID: 6973850
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cross test with B-lymphocytes in transplantation immunology].
    Laurentaci G; Catalano G; Favoino B; Memeo V; Selvaggi FP; Traficante A
    Minerva Chir; 1980 May; 35(10):695-9. PubMed ID: 7005723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. B-cell antibodies and clinical kidney transplantation.
    Myburgh JA; Smit JA
    Transplant Proc; 1978 Sep; 10(3):599-601. PubMed ID: 362641
    [No Abstract]   [Full Text] [Related]  

  • 60. Depletion of the chimeric drug Rituximab from biological samples.
    Book BK; Pescovitz MD; Guo L; Wiebke EA
    Hum Immunol; 2017; 78(7-8):500-502. PubMed ID: 28528708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.